FDC Limited Share Price

FDC Limited Share Price

NSE: FDC
|
Pharmaceuticals
|
S Cap
₹ 356.20
-₹6.20 (-1.71%)
1D
Last updated 22 Sep, 2026, 15:29 IST

FDC Limited Share Price Today

As of 23 Sep 2026, FDC Limited share price is ₹356.20. The stock opened at ₹363.40, compared to its previous close of ₹362.40. During today's trading session, FDC Limited share price moved in the range of ₹355.00 to ₹363.40, with an average price of ₹359.20 for the day. Looking at its last 52-week, the stock has touched a low of ₹312.95 and a high of ₹484.40. On the performance front, FDC Limited share price has increased by 7.11% over the last six months and is down 26.35% on a year-on-year basis.

₹355.00
1.71% down today
₹363.40
1D LOW
1D HIGH

FDC Limited Returns Calculator

Circuit
L
H
₹285.20
₹427.80
52-week
L
H
₹312.95
₹484.40

About FDC Limited

FDC Limited Share Price
ISIN
INE258B01022
Sector Market Cap
₹ 5,902.68 Cr

FDC Limited is an India-based company, which is principally engaged in the business of manufacturing and trading of pharmaceutical products. The Company is specialized in manufacturing Oral Rehydration Solutions (ORS), energy drinks, antibiotics and ophthalmic therapies. Its products include Albuterol Sulfate, Bromhexine Hydrochloride, Cinnarizine, Flunarizine Dihydrochloride, Flurbiprofen Sodium, Miconazole Nitrate, Timolol Maleate, Amoxycillin + Clavulanic Acid, Rupatadine Fumarate, Salbutamol Sulphate, Kaolin Light/ Pectin, among others. The Company’s product offerings cover an extensive range of categories, including anti-infectives, gastrointestinal treatments, ophthalmic, vitamins, minerals, dietary supplements, cardiovascular solutions, anti-diabetics, respiratory care, gynecology, dermatology and analgesics. Its various brands include Zifi, Electral, Enerzal, Vitcofol, Pyrimon, Zocon, Zoxan, Zathrin, Zipod, Zefu, Cotaryl and Mycoderm.

FDC Limited Financial Highlights

  • Revenue: FDC Limited reported revenue of ₹2,284.45 crore in FY26 vs ₹2,198.78 crore in FY25. It showed an increase of 3.90% on a yearly basis.
  • Operating Profit: FDC Limited reported an operating profit of ₹374.60 crore in FY26 vs ₹357.22 crore in FY25. It showed an increase of 4.87% on a year-on-year basis.
  • Net Profit: FDC Limited reported a net profit of ₹281.42 crore in FY26 vs ₹266.79 crore in FY25. It showed an increase of 5.48% on a yearly basis.

FDC Limited Quarterly Result Highlights

  • FDC Limited reported revenue of ₹715.35 crore in Jun 2026, compared with ₹634.68 crore in Mar 2026, representing an increase of 12.71% on a quarter-on-quarter (QoQ) basis.
  • FDC Limited reported an operating profit of ₹174.70 crore in Jun 2026, compared with ₹140.36 crore in Mar 2026, representing an increase of 24.47% on a quarter-on-quarter (QoQ) basis.
  • FDC Limited reported a profit of ₹132.49 crore in Jun 2026, compared with ₹103.40 crore in Mar 2026, reflecting an increase of 28.13% on a QoQ basis.
  • The earnings per share (EPS) of FDC Limited stood at ₹17.29 during Jun 2026.

Data Source: BSE, Company announcements

Securities shown are illustrative, not recommendations. Past performance does not guarantee future results.

Know more
Promoters
69.66%
FII
1.40%
Other DII
0.06%
Retail and other
22.63%
Mutual funds
6.25%
Foreign Institutional Investor (FII)
FII shareholding by period
Sep 20252.43%
Dec 20252.32%
Mar 20262.40%
Jun 20261.40%
Mkt Cap Cr
5,814.76
P/E
19.87
P/B
2.34
ROE
11.32%
D/E
0.01
ROCE
15.18%
Div. Yield
1.38%
EPS(TTM)
17.56
Turnover
0.73
EV/EBITDA
12.93
Net Margin
13.45%
Op. Margin
20.81%
ROA
10.02%
Quick Ratio
2.16
Curr. Ratio
3.18
Based on fundamentals, this stock's
Step 5 of 5
Performance
Excellent
FDC outperforming all market indices
Step 1 of 5
Valuation
Overvalued
FDC appears overvalued compared to its peers
Step 5 of 5
Earnings
Excellent
FDC revenue, operating profit and net profit are growing
Peer Comparison
Peer comparison — key ratios
NameMkt Cap CrP/EP/BROED/EROCEBook ValueDiv. YieldTurnoverEPS(TTM)
Sun Pharmaceutical Industries4,48,196.0036.515.2913.74%0.6117.33%93.240.86%0.4810.90
Divis Laboratories2,50,390.0084.8114.8015.32%0.0019.56%629.490.32%0.5598.19
Torrent Pharmaceuticals1,88,967.0088.0622.5725.49%1.6913.85%222.760.68%0.4958.70
Zydus Lifesciences1,15,860.0025.224.2718.59%0.3117.35%237.300.09%0.3335.38
Cipla1,11,888.0033.253.2411.27%0.0014.95%423.360.94%0.4543.52
Laurus Labs1,08,338.0099.3620.4416.77%0.4016.14%97.200.10%0.6713.72
Mankind Pharma1,00,364.0049.536.2811.74%0.3413.13%396.980.04%0.4449.37
Dr. Reddy's Laboratories1,00,329.0031.782.6611.07%0.1812.54%377.950.66%0.4138.68
Aurobindo Pharma98,803.9026.312.589.25%0.1911.76%394.820.24%0.3841.58
Lupin96,950.0017.474.3223.76%0.0424.88%658.960.85%0.57129.18

Auto-generated based on historical fundamentals; not a recommendation to buy/sell.

FDC Limited Financials

Full statement

Income Statement · Consolidated

Income Statement · Consolidated — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Revenue₹2,170.93₹2,108.12₹1,942.94₹1,783.75
Other Income₹113.52₹90.66₹101.63₹49.86
Total Revenue₹2,284.45₹2,198.78₹2,044.58₹1,833.61
Total Expenses₹1,889.06₹1,841.56₹1,648.36₹1,575.80
Profit Before Tax₹374.60₹357.22₹396.22₹257.80
Tax₹93.18₹90.43₹91.16₹63.98
Profit After Tax₹281.42₹266.79₹305.06₹193.83
EPS - Basic₹17.29₹16.39₹18.58₹11.66
EPS - Diluted₹17.29₹16.39₹18.58₹11.66

Cash Flow · Consolidated

Cash Flow · Consolidated — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Profit before tax₹374.60₹357.22₹396.22₹257.80
Income before WC changes₹341.51₹332.44₹345.04₹262.12
Change in Assets-₹55.53₹40.70-₹39.06-₹86.03
Change in Liabilities₹1.64₹47.23₹18.71₹56.13
Change in WC-₹53.89₹87.94-₹20.35-₹29.91
Cash flow from Operations₹200.45₹317.57₹220.77₹154.91
Cash flow from Investing-₹109.93-₹199.51-₹17.08₹11.13
Cash flow from Financing-₹93.33-₹92.12-₹202.16-₹179.95
Total Cash Flow-₹2.80₹25.94₹1.53-₹13.90
Cash (Start of the year)₹51.47₹25.42₹23.89₹37.73
Cash (End of the year)₹48.68₹51.47₹25.42₹23.89

Balance Sheet · Consolidated

Balance Sheet · Consolidated — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Non-Current Assets₹1,786.44₹1,625.09₹1,401.60₹1,317.88
Current Assets₹1,132.52₹1,088.72₹1,066.49₹1,025.06
Total Assets₹2,918.97₹2,713.80₹2,468.09₹2,342.94
Current Liabilities₹364.07₹361.64₹310.62₹311.56
Net Current Asset₹768.45₹727.08₹755.87₹713.50
Non-Current Liabilities₹69.78₹71.08₹60.30₹49.98
Equity Capital₹2,485.11₹2,281.08₹2,097.17₹1,981.40
Total Equity & Liabilities₹2,918.97₹2,713.80₹2,468.09₹2,342.94

Income Statement · Standalone

Income Statement · Standalone — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Revenue₹2,126.33₹2,070.11₹1,916.19₹1,777.03
Other Income₹111.00₹105.52₹103.22₹53.91
Total Revenue₹2,237.33₹2,175.63₹2,019.40₹1,830.94
Total Expenses₹1,838.18₹1,807.96₹1,621.46₹1,565.25
Profit Before Tax₹378.36₹367.67₹397.95₹265.69
Tax₹92.44₹94.05₹90.78₹64.72
Profit After Tax₹285.92₹273.63₹307.16₹200.97
EPS - Basic₹17.56₹16.81₹18.70₹12.09
EPS - Diluted₹17.56₹16.81₹18.70₹12.09

Cash Flow · Standalone

Cash Flow · Standalone — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Profit before tax₹378.36₹367.67₹397.95₹265.69
Income before WC changes₹343.51₹327.76₹345.62₹266.69
Change in Assets-₹53.64₹42.19-₹38.27-₹81.61
Change in Liabilities-₹3.47₹43.21₹16.36₹56.50
Change in WC-₹57.11₹85.40-₹21.91-₹25.11
Cash flow from Operations₹200.17₹310.34₹220.81₹164.72
Cash flow from Investing-₹109.24-₹199.45-₹17.76₹3.62
Cash flow from Financing-₹93.15-₹92.10-₹202.03-₹179.83
Total Cash Flow-₹2.22₹18.79₹1.02-₹11.49
Cash (Start of the year)₹39.67₹20.77₹19.75₹31.13
Cash (End of the year)₹37.47₹39.67₹20.77₹19.75

Balance Sheet · Standalone

Balance Sheet · Standalone — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Non-Current Assets₹1,802.93₹1,642.26₹1,404.06₹1,311.66
Current Assets₹1,109.44₹1,068.06₹1,054.57₹1,023.76
Total Assets₹2,912.37₹2,710.32₹2,458.63₹2,335.42
Current Liabilities₹354.22₹355.01₹307.67₹310.69
Net Current Asset₹755.22₹713.05₹746.90₹713.07
Non-Current Liabilities₹65.51₹68.12₹53.76₹43.99
Equity Capital₹2,492.64₹2,287.19₹2,097.20₹1,980.74
Total Equity & Liabilities₹2,912.37₹2,710.32₹2,458.63₹2,335.42
* All values are in INR Crore
Qty
Bid
0
0
0
0
0
0
0
0
0
0
Ask
Qty
356.5
1
0
0
0
0
0
0
0
0
Bid Total: 0
Ask Total: 1
Buy orders: 0%
Sell orders: 100%
Bearish
1
Neutral
6
Bullish
1
Neutral
by SEBI experts
Expert Pick
EXPPICK
Stop-loss
Entry price
Target
Indicator
Value
Verdict
RSI (14)
51.71
Neutral
ATR (14)
10.5
Neutral
STOCH(9,6)
65.79
Neutral
STOCH RSI (14)
78.06
Neutral
ADX(9)
36.34
Bearish
UO(9)
56.96
Neutral
ROC(12)
4.36
Bullish
WillR(14)
-24.73
Neutral
Period
Simple value
Exponential vaue
5D
354.75
355.04
10D
351.05
351.97
20D
346.28
351.84
50D
370.82
363.92
100D
382.29
372.8
Volume trend — traded volume by day
22 Sep0L
21 Sep2L
18 Sep1L
17 Sep0L
16 Sep2L
Average1L

Technical indicators used here are for indicative purposes only. Kindly do not treat it as an investment or trading advice

Compare against other stocks
FDC Limited Share Price
FDC Limited
Pharmaceuticals
Add Stock
Add Another

FDC Limited Share Price FAQs

FDC Limited share price data is sourced from NSE/BSE and may be delayed. It is displayed for informational purposes only and does not constitute investment advice or a recommendation to buy or sell.

Trusted by 2 Crore+ Indians for their wealth-building needs. SEBI Registered Broker. SEBI Reg No. INZ000315837